RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINESА. Е. Каратеев, Н. В. Чичасова, S. S. Kopenkin et al.|Rheumatology Science and Practice|2018Cited by 151
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of RussiaЕ. Л. Насонов, А. I. Zagrebneva, А. М. Лила et al.|Rheumatology Science and Practice|2021Cited by 54
Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature reviewЕ. Л. Насонов, A. Yu. Zimenko, Б. С. Белов et al.|Rheumatology Science and Practice|2021Cited by 14
Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issuesБ. С. Белов, Е. Л. Насонов, А. М. Лила|Rheumatology Science and Practice|2022Cited by 13
COVID-19 and rheumatology: A year laterБ. С. Белов, А. М. Лила|Rheumatology Science and Practice|2021Cited by 10